Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%

By García-Feijoo J.   Martínez-de-la-Casa J. M.   Castillo A.   Méndez C.   Fernández-Vidal A.   García-Sánchez J.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1689-1697

Informa Healthcare

Access to resources Recommend Favorite

Comparing bimatoprost and travoprost in black Americans

By Noecker Robert J.   Earl Melissa L.   Mundorf Thomas K.   Silverstein Steven M.   Phillips Michael P.  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2175-2180

Informa Healthcare

Access to resources Recommend Favorite

Influence of switching to travoprost on intraocular pressure of uncontrolled chronic open-angle glaucoma patients compliant to previously-used topical medication

By Holló Gábor   Vargha Péter   Kóthy Péter  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1943-1948

Informa Healthcare

Access to resources Recommend Favorite

Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma

By Holló Gábor   Kóthy Péter  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1755-1761

Informa Healthcare

Access to resources Recommend Favorite

An adherence based cost–consequence model comparing bimatoprost 0.01% to bimatoprost 0.03%

By Wong William B.   Patel Vaishali D.   Kowalski Jonathan W.   Schwartz Gail  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1191-1200

Informa Healthcare

Access to resources Recommend Favorite